✦ LIBER ✦

How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations

✍ Scribed by Hisao Asamura; Tomoyuki Goya; Yoshihiko Koshiishi; Yasunori Sohara; Ryosuke Tsuchiya; Etsuo Miyaoka

Book ID: 113760912
Publisher: CTSNet
Year: 2006
Tongue: English
Weight: 190 KB
Volume: 132
Category: Article
ISSN: 1097-685X
DOI: 10.1016/j.jtcvs.2006.03.048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Post-operative staging and survival base

Post-operative staging and survival based on the revised tnm staging system for non-small cell lung cancer

✍ Yi-long Wu; Zhi-fan Huang; Si-yu Wang; Xue-ning Yang 📂 Article 📅 2000 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 274 KB

Should Pleural Fluid Cytology Be Incorpo

Should Pleural Fluid Cytology Be Incorporated in the TNM Staging System for Operable Nonsmall Cell Lung Cancer?

✍ C.S. Pramesh; Rajesh C. Mistry; Jaiprakash Agarwal; Ramesh Bishnoi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Surgical results for small cell lung can

Surgical results for small cell lung cancer based on the new TNM staging system

✍ Masayoshi Inoue; Shinichiro Miyoshi; Tsutomu Yasumitsu; Takashi Mori; Keiji Iuch 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 308 KB

Prognostic evaluation based on a new TNM

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small cell lung cancers

✍ Takayuki Fukui; Shoichi Mori; Shunzo Hatooka; Masayuki Shinoda; Tetsuya Mitsudom 📂 Article 📅 2008 🏛 CTSNet 🌐 English ⚖ 335 KB

Impact of tumor size on outcomes after a

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system

✍ Shamus R. Carr; Matthew J. Schuchert; Arjun Pennathur; David O. Wilson; Jill M. 📂 Article 📅 2012 🏛 CTSNet 🌐 English ⚖ 469 KB

Prognostic factors for survival of stage

Prognostic factors for survival of stage I nonsmall cell lung cancer patients : A population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003

✍ S.-H. Ignatius Ou; Jason A. Zell; Argyrios Ziogas; Hoda Anton-Culver 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

## Abstract ## BACKGROUND. Platinum‐based adjuvant chemotherapy in randomized trials has failed to provide a survival benefit in patients with resected stage I nonsmall cell lung cancer (NSCLC). Using data from the California Cancer Registry (CCR), we explored factors that had detrimental effects